TAK1 Is Essential for Osteoclast Differentiation and Is an Important Modulator of Cell Death by Apoptosis and Necroptosis

REFERENCES

• Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J. 1999. RANK is essential for osteoclast and lymph node development. Genes Dev. 13:2412–2424.
   PubMed Web of Science ®Google Scholar
• Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315–323.
   PubMed Web of Science ®Google Scholar
• Darnay BG, Besse A, Poblenz AT, Lamothe B, Jacoby JJ. 2007. TRAFs in RANK signaling. Adv. Exp. Med. Biol. 597:152–159.
   PubMed Web of Science ®Google Scholar
• Teitelbaum SL. 2007. Osteoclasts: what do they do and how do they do it? Am. J. Pathol. 170:427–435.
   PubMed Web of Science ®Google Scholar
• Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S, van der Heiden A, Itie A, Wakeham A, Khoo W, Sasaki T, Cao Z, Penninger JM, Paige CJ, Lacey DL, Dunstan CR, Boyle WJ, Goeddel DV, Mak TW. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1015–1024.
   PubMed Web of Science ®Google Scholar
• Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, Takatsu K, Nakao K, Nakamura K, Katsuki M, Yamamoto T, Inoue J. 1999. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4:353–362.
   PubMed Web of Science ®Google Scholar
• Lamothe B, Campos AD, Webster WK, Gopinathan A, Hur L, Darnay BG. 2008. The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. J. Biol. Chem. 283:24871–24880.
   PubMed Web of Science ®Google Scholar
• Lamothe B, Webster WK, Gopinathan A, Besse A, Campos AD, Darnay BG. 2007. TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem. Biophys. Res. Commun. 359:1044–1049.
   PubMedGoogle Scholar
• Otero JE, Dai S, Foglia D, Alhawagri M, Vacher J, Pasparakis M, Abu-Amer Y. 2008. Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation. J. Biol. Chem. 283:24546–24553.
   PubMedGoogle Scholar
• Ruocco MG, Maeda S, Park JM, Lawrence T, Hsu LC, Cao Y, Schett G, Wagner EF, Karin M. 2005. I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J. Exp. Med. 201:1677–1687.
   PubMed Web of Science ®Google Scholar
• Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O, Akira S. 2005. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6:1087–1095.
   PubMed Web of Science ®Google Scholar
• Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS, Lee KY, Bussey C, Steckel M, Tanaka N, Yamada G, Akira S, Matsumoto K, Ghosh S. 2005. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19:2668–2681.
   PubMed Web of Science ®Google Scholar
• Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ. 2000. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103:351–361.
   PubMed Web of Science ®Google Scholar
• Lamothe B, Besse A, Campos AD, Webster WK, Wu H, Darnay BG. 2007. Site-specific Lys-63-linked tumor necrosis factor receptor-associated Factor 6 auto-ubiquitination is a critical determinant of IkappaB kinase activation. J. Biol. Chem. 282:4102–4112.
   PubMed Web of Science ®Google Scholar
• Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346–351.
   PubMed Web of Science ®Google Scholar
• Yin Q, Lin SC, Lamothe B, Lu M, Lo YC, Hura G, Zheng L, Rich RL, Campos AD, Myszka DG, Lenardo MJ, Darnay BG, Wu H. 2009. E2 interaction and dimerization in the crystal structure of TRAF6. Nat. Struct. Mol. Biol. 16:658–666.
   PubMed Web of Science ®Google Scholar
• Huang H, Ryu J, Ha J, Chang EJ, Kim HJ, Kim HM, Kitamura T, Lee ZH, Kim HH. 2006. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL. Cell Death Differ. 13:1879–1891.
   PubMed Web of Science ®Google Scholar
• Lee SW, Han SI, Kim HH, Lee ZH. 2002. TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB. J. Biochem. Mol. Biol. 35:371–376.
   PubMedGoogle Scholar
• Mizukami J, Takaesu G, Akatsuka H, Sakurai H, Ninomiya-Tsuji J, Matsumoto K, Sakurai N. 2002. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol. Cell. Biol. 22:992–1000.
   PubMedGoogle Scholar
• Besse A, Lamothe B, Campos AD, Webster WK, Maddineni U, Lin SC, Wu H, Darnay BG. 2007. TAK1-dependent signaling requires functional interaction with TAB2/TAB3. J. Biol. Chem. 282:3918–3928.
   PubMedGoogle Scholar
• Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265–277.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S. 2007. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130:811–823.
   PubMed Web of Science ®Google Scholar
• Xie M, Zhang D, Dyck JR, Li Y, Zhang H, Morishima M, Mann DL, Taffet GE, Baldini A, Khoury DS, Schneider MD. 2006. A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc. Natl. Acad. Sci. U. S. A. 103:17378–17383.
   PubMed Web of Science ®Google Scholar
• Poblenz AT, Jacoby JJ, Singh S, Darnay BG. 2007. Inhibition of RANKL-mediated osteoclast differentiation by selective TRAF6 decoy peptides. Biochem. Biophys. Res. Commun. 359:510–515.
   PubMed Web of Science ®Google Scholar
• Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2:595–610.
   PubMed Web of Science ®Google Scholar
• Micheau O, Tschopp J. 2003. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181–190.
   PubMed Web of Science ®Google Scholar
• Ajibade AA, Wang Q, Cui J, Zou J, Xia X, Wang M, Tong Y, Hui W, Liu D, Su B, Wang HY, Wang RF. 2012. TAK1 negatively regulates NF-kappaB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils. Immunity 36:43–54.
   PubMedGoogle Scholar
• Omori E, Matsumoto K, Sanjo H, Sato S, Akira S, Smart RC, Ninomiya-Tsuji J. 2006. TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J. Biol. Chem. 281:19610–19617.
   PubMed Web of Science ®Google Scholar
• Omori E, Morioka S, Matsumoto K, Ninomiya-Tsuji J. 2008. TAK1 regulates reactive oxygen species and cell death in keratinocytes, which is essential for skin integrity. J. Biol. Chem. 283:26161–26168.
   PubMedGoogle Scholar
• Sato S, Sanjo H, Tsujimura T, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Takeuchi O, Akira S. 2006. TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells. Int. Immunol. 18:1405–1411.
   PubMedGoogle Scholar
• Wan YY, Chi H, Xie M, Schneider MD, Flavell RA. 2006. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat. Immunol. 7:851–858.
   PubMedGoogle Scholar
• Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD. 2007. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178:5245–5252.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G. 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16:3–11.
   PubMed Web of Science ®Google Scholar
• Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. 2010. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11:700–714.
   PubMed Web of Science ®Google Scholar
• Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J. 2008. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4:313–321.
   PubMed Web of Science ®Google Scholar
• Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T. 2010. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci. Signal. 3:re4. doi:10.1126/scisignal.3115re4.
   PubMed Web of Science ®Google Scholar
• Fan Y, Yu Y, Shi Y, Sun W, Xie M, Ge N, Mao R, Chang A, Xu G, Schneider MD, Zhang H, Fu S, Qin J, Yang J. 2010. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation. J. Biol. Chem. 285:5347–5360.
   PubMed Web of Science ®Google Scholar
• Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, Caspary T, Mocarski ES. 2011. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471:368–372.
   PubMed Web of Science ®Google Scholar
• Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS, Green DR. 2011. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471:363–367.
   PubMed Web of Science ®Google Scholar
• Upton JW, Kaiser WJ, Mocarski ES. 2010. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7:302–313.
   PubMed Web of Science ®Google Scholar
• Ito Y, Teitelbaum SL, Zou W, Zheng Y, Johnson JF, Chappel J, Ross FP, Zhao H. 2010. Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization. J. Clin. Invest. 120:1981–1993.
   PubMed Web of Science ®Google Scholar
• Iwasawa M, Miyazaki T, Nagase Y, Akiyama T, Kadono Y, Nakamura M, Oshima Y, Yasui T, Matsumoto T, Nakamura T, Kato S, Hennighausen L, Nakamura K, Tanaka S. 2009. The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice. J. Clin. Invest. 119:3149–3159.
   PubMedGoogle Scholar
• Yang C, McCoy K, Davis JL, Schmidt-Supprian M, Sasaki Y, Faccio R, Novack DV. 2010. NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis. PLoS One 5:e15383. doi:10.1371/journal.pone.0015383.
   PubMedGoogle Scholar
• Mizoguchi F, Izu Y, Hayata T, Hemmi H, Nakashima K, Nakamura T, Kato S, Miyasaka N, Ezura Y, Noda M. 2010. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption. J. Cell. Biochem. 109:866–875.
   PubMed Web of Science ®Google Scholar
• Miyauchi Y, Ninomiya K, Miyamoto H, Sakamoto A, Iwasaki R, Hoshi H, Miyamoto K, Hao W, Yoshida S, Morioka H, Chiba K, Kato S, Tokuhisa T, Saitou M, Toyama Y, Suda T, Miyamoto T. 2010. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. J. Exp. Med. 207:751–762.
   PubMed Web of Science ®Google Scholar
• Croke M, Ross FP, Korhonen M, Williams DA, Zou W, Teitelbaum SL. 2011. Rac deletion in osteoclasts causes severe osteopetrosis. J. Cell Sci. 124:3811–3821.
   PubMedGoogle Scholar
• Liu HH, Xie M, Schneider MD, Chen ZJ. 2006. Essential role of TAK1 in thymocyte development and activation. Proc. Natl. Acad. Sci. U. S. A. 103:11677–11682.
   PubMedGoogle Scholar
• O'Donnell MA, Legarda-Addison D, Skountzos P, Yeh WC, Ting AT. 2007. Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling. Curr. Biol. 17:418–424.
   PubMed Web of Science ®Google Scholar
• McComb S, Cheung HH, Korneluk RG, Wang S, Krishnan L, Sad S. 2012. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death Differ. 19:1791–1801.
   PubMed Web of Science ®Google Scholar
• Wu YT, Tan HL, Huang Q, Sun XJ, Zhu X, Shen HM. 2011. zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFalpha mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ. 18:26–37.
   PubMedGoogle Scholar
• Christofferson DE, Li Y, Hitomi J, Zhou W, Upperman C, Zhu H, Gerber SA, Gygi S, Yuan J. 2012. A novel role for RIP1 kinase in mediating TNFalpha production. Cell Death Dis. 3:e320. doi:10.1038/cddis.2012.64.
   PubMed Web of Science ®Google Scholar
• Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, Yuan J. 2008. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135:1311–1323.
   PubMed Web of Science ®Google Scholar
• Arslan SC, Scheidereit C. 2011. The prevalence of TNFalpha-induced necrosis over apoptosis is determined by TAK1-RIP1 interplay. PLoS One 6:e26069. doi:10.1371/journal.pone.0026069.
   PubMedGoogle Scholar
• Wang L, Du F, Wang X. 2008. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133:693–703.
   PubMed Web of Science ®Google Scholar
• Vanlangenakker N, Vanden Berghe T, Bogaert P, Laukens B, Zobel K, Deshayes K, Vucic D, Fulda S, Vandenabeele P, Bertrand MJ. 2011. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ. 18:656–665.
   PubMed Web of Science ®Google Scholar
• Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK. 2009. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137:1112–1123.
   PubMed Web of Science ®Google Scholar
• Schuman J, Chen Y, Podd A, Yu M, Liu HH, Wen R, Chen ZJ, Wang D. 2009. A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation. Blood 113:4566–4574.
   PubMed Web of Science ®Google Scholar
• Mellis DJ, Itzstein C, Helfrich MH, Crockett JC. 2011. The skeleton: a multi-functional complex organ: the role of key signalling pathways in osteoclast differentiation and in bone resorption. J. Endocrinol. 211:131–143.
   PubMed Web of Science ®Google Scholar
• David JP, Sabapathy K, Hoffmann O, Idarraga MH, Wagner EF. 2002. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J. Cell Sci. 115:4317–4325.
   PubMed Web of Science ®Google Scholar
• Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T, Suda T, Takahashi N. 2002. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143:3105–3113.
   PubMedGoogle Scholar
• Matsumoto M, Sudo T, Saito T, Osada H, Tsujimoto M. 2000. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J. Biol. Chem. 275:31155–31161.
   PubMed Web of Science ®Google Scholar
• Sayama K, Hanakawa Y, Nagai H, Shirakata Y, Dai X, Hirakawa S, Tokumaru S, Tohyama M, Yang L, Sato S, Shizuo A, Hashimoto K. 2006. Transforming growth factor-beta-activated kinase 1 is essential for differentiation and the prevention of apoptosis in epidermis. J. Biol. Chem. 281:22013–22020.
   PubMedGoogle Scholar
• Buhling F, Rocken C, Brasch F, Hartig R, Yasuda Y, Saftig P, Bromme D, Welte T. 2004. Pivotal role of cathepsin K in lung fibrosis. Am. J. Pathol. 164:2203–2216.
   PubMed Web of Science ®Google Scholar
• Quintanilla-Dieck MJ, Codriansky K, Keady M, Bhawan J, Runger TM. 2009. Expression and regulation of cathepsin K in skin fibroblasts. Exp. Dermatol. 18:596–602.
   PubMed Web of Science ®Google Scholar
• Runger TM, Quintanilla-Dieck MJ, Bhawan J. 2007. Role of cathepsin K in the turnover of the dermal extracellular matrix during scar formation. J. Invest. Dermatol. 127:293–297.
   PubMed Web of Science ®Google Scholar
• Boonen S, Rosenberg E, Claessens F, Vanderschueren D, Papapoulos S. 2012. Inhibition of cathepsin K for treatment of osteoporosis. Curr. Osteoporos. Rep. 10:73–79.
   PubMed Web of Science ®Google Scholar
• Greenblatt MB, Shim JH, Zou W, Sitara D, Schweitzer M, Hu D, Lotinun S, Sano Y, Baron R, Park JM, Arthur S, Xie M, Schneider MD, Zhai B, Gygi S, Davis R, Glimcher LH. 2010. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J. Clin. Invest. 120:2457–2473.
   PubMed Web of Science ®Google Scholar
• Eftychi C, Karagianni N, Alexiou M, Apostolaki M, Kollias G. 2012. Myeloid TAKL acts as a negative regulator of the LPS response and mediates resistance to endotoxemia. PLoS One 7:e31550. doi:10.1371/journal.pone.0031550.
   PubMedGoogle Scholar